Fecal microbiota for peanut hypersensitivity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Nov 2016: Trial registered, NCT02960074
  2. 3 Mar 2017: Trial started, NCT02960074

The trials

NCT02960074: Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients

State
Completed
Phase
Phase 1
People
15 taking part
Started
3 Mar 2017
Primary completion
28 Jul 2021
Arms
Non-antibiotics Arm, Antibiotics Arm
Results
None posted
  1. 9 Nov 2016: Trial registered
  2. 3 Mar 2017: Trial started
  3. 28 Jul 2021: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Also known as Fecal Microbiota Capsule, Fecal Microbiota Preparation, Fecal microbiota transplant G3 capsules, Human fecal matter, Lyophilized Fecal Microbiota Transplantation, faecal human microbiota transplant (FMT).

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.